There are now two fully approved drugs on the market that can, sometimes, slow down the progression of Alzheimer's disease. Both have been shown to slow down the mental decline of Alzheimer's by more than 25%. But that's in a group of patients—an individual may do much better, or not be helped at all. NPR Science Correspondent <a href="https://www.npr.org/people/2100615/jon-hamilton">Jon Hamilton</a> has been talking to people who've taken these drugs. Today he has the story of two patients to receive them. Interested in more human health stories? Contact us at <a href="mailto:shortwave@npr.org">shortwave@npr.org</a>. Listen to every episode of Short Wave sponsor-free and support our work at NPR by signing up for Short Wave+ at <a href="http://plus.npr.org/shortwave">plus.npr.org/shortwave</a>. Learn more about sponsor message choices: <a href="https://podcastchoices.com/adchoices">podcastchoices.com/adchoices</a> <a href="https://www.npr.org/about-npr/179878450/privacy-policy">NPR Privacy Policy</a>

Podurama

Home

Trending

Personal

Your Podcasts

New Episodes

My Files

Favourite Episodes

Tags (Folders)

Recently Played

Bookmarks

Followed Playlists

What It's Like Taking Alzheimer's Drugs

Short Wave

AI Chapters

AI Insights

Reviews